Proposed dividend for year ended 30 September 2012

RNS Number : 5718T

The MedicX Fund Limited

08 December 2011

 



For immediate release                                                                                                 8 December 2011

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Proposed dividend for year ended 30 September 2012

The Board of MedicX Fund Limited (the "Company") are pleased to announce that the Company expects, subject to unforeseen circumstances, to pay dividends totalling 5.6p per Ordinary Share in respect of the financial year ending 30 September 2012, an increase of 0.1p per Ordinary Share from the 5.5p per Ordinary Share for the financial year ended 30 September 2011.

The first interim dividend in respect of that financial year of 1.4p per Ordinary Share is intended to be paid to shareholders on 31 March 2012.

The Company pays dividends on a quarterly basis comprising of four equal quarterly dividends payable on the last business day of March, June, September and December of each year.  Shareholders can elect for scrip dividends in lieu of cash dividends in respect of the Company's quarterly dividend payments.

End

For further information please contact:

MedicX Group                                                              [phone]

Keith Maddin, Chairman

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

MedicX Fund                                                                [phone]

David Staples, Chairman

Collins Stewart Europe Limited                                      [phone]

Andrew Zychowski/Helen Goldsmith

Buchanan Communications                                            [phone]

Charles Ryland/Suzanne Brocks

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 63 properties.

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 26 people operating across the UK.  

The Company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), are incorporated into, or forms part of, this announcement.

 

END

 

 

DIVEAAAXEFNFFAF